RETATRUTIDE (RETA) Third-Party Tested COA Available Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors
Tirzepatide is generally studied as a dual GIP and GLP-1 receptor agonist, while Retatrutide is studied as a triple receptor agonist involving GIP, GLP-1, and glucagon receptor pathways
Retatrutide (10 mg) is a synthetic peptide engineered as a triple receptor agonist
They are not for human consumption, medical, or veterinary use
These informal terms are often used because Retatrutide is studied across three receptor pathways rather than one
Below are some additional tips for the proper storage of retatrutide: Avoid storing in the bathroom: Indoor environmental moisture can compromise the peptides stability